نتایج جستجو برای: 177lu psma

تعداد نتایج: 2383  

Journal: :Biomedicines 2021

متن کامل
Journal: :Journal of Nuclear Medicine 2016

متن کامل
Journal: :Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2016
Clemens Kratochwil Frederik L Giesel Melsa Stefanova Martina Benešová Marcus Bronzel Ali Afshar-Oromieh Walter Mier Matthias Eder Klaus Kopka Uwe Haberkorn

UNLABELLED Prostate-specific membrane antigen (PSMA) is an excellent target for radionuclide therapy of metastasized castration-resistant prostate cancer (mCRPC). Besides high affinity and long tumor retention, the DOTA-conjugated ligand PSMA-617 has low kidney uptake, making it an excellent choice for therapeutic application. We retrospectively report our experience with (177)Lu-PSMA-617-targe...

متن کامل
Journal: :EJNMMI Research 2017

متن کامل
Journal: :Journal of Nuclear Medicine & Radiation Therapy 2016

متن کامل
Journal: :Brazilian Journal of Radiation Sciences 2021

متن کامل
Journal: :European Journal of Nuclear Medicine and Molecular Imaging 2020

متن کامل
Journal: :European Journal of Nuclear Medicine and Molecular Imaging 2021

متن کامل
2015
Ada H. V. Repetto-Llamazares Roy H. Larsen Sebastian Patzke Karianne G. Fleten David Didierlaurent Alexandre Pichard Jean Pierre Pouget Jostein Dahle Ken Mills

177Lu-DOTA-HH1 (177Lu-HH1) is a novel anti-CD37 radioimmunoconjugate developed to treat non-Hodgkin lymphoma. Mice with subcutaneous Ramos xenografts were treated with different activities of 177Lu-HH1, 177Lu-DOTA-rituximab (177Lu-rituximab) and non-specific 177Lu-DOTA-IgG1 (177Lu-IgG1) and therapeutic effect and toxicity of the treatment were monitored. Significant tumor growth delay and incre...

متن کامل
Journal: :Oncotarget 2019

متن کامل

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید